Morten Scheibye-Knudsen

Morten Scheibye-Knudsen is an Associate Professor in the Department of Cellular and Molecular Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. He leads the Scheibye-Knudsen Group within the Molecular Aging Program at the Center for Healthy Aging, focusing on DNA damage and repair mechanisms in aging. His research aims to develop interventions that promote healthier aging and address age-associated diseases including Alzheimer's, Parkinson's, and cardiovascular conditions.

Dr. Scheibye-Knudsen's research primarily investigates how DNA damage leads to changes in cellular metabolites and how replenishing these molecules might alter aging rates in model organisms. His work spans multiple methodologies including in silico analyses, in vitro biochemistry, molecular biology, and in vivo mouse models. Key research areas include cellular senescence, mitochondrial function, metabolic pathways in aging, and neurodegenerative disease mechanisms. His laboratory has made significant discoveries connecting DNA damage signaling to organismal aging processes.

His recent publications demonstrate a strong focus on applying advanced technologies like deep learning to aging research, with studies examining cellular senescence patterns, breast cancer risk prediction, altitude effects on aging, and progeria phenotyping. The research output shows increasing interdisciplinary collaboration, combining computational approaches with traditional molecular biology techniques.

Dr. Scheibye-Knudsen holds several significant professional roles beyond his academic position: he is president of the Nordic Aging Society, chief editor at Frontiers in Aging, owner of MSK Consulting, and serves as CSO for the Healthy Longevity Clinic. He also consults for BOLD Longevity Growth Fund and Deep Longevity, demonstrating strong industry connections in the longevity field.

His laboratory, the Scheibye-Knudsen Group, operates within the Center for Healthy Aging at the University of Copenhagen, focusing on translating basic research on DNA damage into potential interventions for age-related conditions. The group's mission statement explicitly aims to 'discover interventions leading to healthier, happier and more productive lives,' reflecting a practical, intervention-focused approach to aging research.